Classifications

• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
  • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
  • G01N33/54306—Solid-phase reaction mechanisms
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
  • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
  • G01N33/54366—Apparatus specially adapted for solid-phase testing
  • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
  • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Definitions

• This invention relates to a method determining concentration, charge or unit size of a substance.
• Proteins have been precipitated using different strategies and compounds for the determination of total protein concentration.
• Precipitants such as trichloroacetic acid, sulphosalicylic acid, benzethonium chloride and benzalkonium chloride have been applied to obtain aggregates which have been measured for concentration using nephelometry (Shephard MD, Whiting MJ, Ann. Clin. Biochem., 1992, 29, 411 ). Also turbidimetry has been applied for the concentration measurement.
• fluorescence resonance energy transfer between soluble donor and acceptor units is typically based on specific binders such as antibodies and other ligands.
• specific binders such as antibodies and other ligands.
• surface and particle- based resonance energy transfer methods WO 98/15830; WO 00/23785; US 2004/0076948; Fl 20030460; Kokko L et al., Anal. Chim. Acta, 2004, 503, 155).
• particle-based methods such as luminescent oxygen channelling immunoassay and scintillation proximity assay, also utilize specific binders on particles to detect the presence of analyte molecules (US 6,406,913; US 6,524,786).
• Above-mentioned methods are separation-free system where no washing steps within the time course of the assay are performed.
• Well-known other separation-free assay methods are, for example, two-photon excitation, fluorescence polarization, fluorescence correlation, solid-surface scintillation and flow cytometric assays (Hanninen P et al., Nature Biotech. 2000, 18, 548; Park SH, Raines RT, Methods MoI Biol.
• Unit size such as particle size of a sample has been traditionally measured using light scattering, photon correlation and polarization intensity differential scattering. These methods can typically measure size of a sample above 10 nm. Recently, back scattering method has been claimed to measure reliable sizes below 10 nm. Whether large or small particles are being measured, the existing methods rely largely on the use of scattering of the particulates.
• One object of the present invention is to provide a method suitable for determining concentration, charge and/or unit size of a substance to be analyzed, i.e. a sample substance.
• the present invention provides a method comprising the steps of a) contacting a sample containing a sample substance and a solid phase, and optionally a substance containing a signal element, i.e. a signal element substance; wherein at least one of said sample substance, said solid phase, and said signal element substance comprises a signal element; wherein the surface of the solid phase contains no specific binding partners; and wherein the solid phase is capable of binding said sample substance nonspecifically, preferably through adsorption, to said solid phase, and b) detecting a signal change resulted from i) binding of said sample substance and/or signal element substance to said solid phase, and/or ii) change in distance from said sample substance and/or said signal element substance to said solid phase.
• Figure 1 illustrates the principle of a state-of-the-art method using specific binding partners on a solid surface.
• the surface contains a signal element and a specific binder is attached onto the surface. Fluorescence resonance energy signal is measured upon binding of a labelled competitive substance (A). When a sample substance is introduced the signal is altered and less resonance energy signal is detected (B).
• Figure 2 illustrates the principle of a surface recognition analysis.
• the signal of the solid-phase surface is altered upon binding of a sample substance.
• Figure 3 illustrates the principle of a competition analysis.
• a competitive substance (A) containing one member of a signal element pair binds onto the solid-phase containing the other member of a signal element pair and a signal is generated.
• Sample substance (B) is capable of binding onto solid-phase surface blocking the access of the competitive substance containing one member of a signal element pair to the solid phase.
• Figure 4 illustrates the principle of a complex analysis.
• sample substance, an antigen is competing with a competitive substance, an antigen containing one member of a signal element pair, for a specific binding substance, an antibody (A).
• A an antibody
• B the complexes of sample and specific binding substances and/or competitive and specific binding substances are attached onto the solid-phase surface containing the other member of a signal element pair (B).
• the binding partners can also be added into the reaction volume simultaneously.
• the signal is altered and detected upon binding.
• Figure 5 illustrates the principle of a multi surface analysis.
• the sample substance is interacting with a solid surface (A).
• a particle containing a signal element is contacting the sample (B).
• the signal is monitored in a separation or separation-free assay format.
• Figure 6 illustrates a competition analysis and concentration measurement of bovine serum albumin on carboxylated europium(lll)-chelate embedded nanoparticles.
• bovine serum albumin was attached to the surface of the nanoparticle and, thereafter, the remaining free surface sites were occupied by bovine serum albumin labelled with Alexa680 dye.
• the long-lived fluorescence energy transfer signal was monitored at 730 nm.
• Figure 7 illustrates a competition analysis of bovine serum albumin on Cy5-dyed surface.
• bovine serum albumin was attached onto the surface and, thereafter, the remaining free binding sites were occupied by europium(lll)-labelled streptavidin.
• the time-resolved fluorescence signal was monitored at 665 nm. When the surface of the Cy5 was covered with albumin, no significant time- resolved fluorescence energy transfer signal was obtained.
• Figure 8 illustrates a competition analysis and concentration measurement of estradiol on carboxylated europium(lll)-chelate embedded nanoparticles.
• estrdiol was attached to the surface of the nanoparticle and, thereafter, the remaining free surface sites were occupied by estradiol labelled with Alexa680 dye.
• the long-lived fluorescence energy transfer signal was monitored at 730 nm.
• Figure 9 illustrates a competition analysis and concentration measurement of five different cell types on carboxylated europium(lll)-chelate embedded nanoparticles.
• cells were attached to the surface of the nanoparticle and, thereafter, the remaining free surface sites were occupied by bovine serum albumin labelled with Alexa ⁇ O dye.
• the long-lived fluorescence energy transfer signal was monitored at 730 nm.
• Figure 10 illustrates a competition analysis and unit size measurement of monoclonal antibody or myoglobin proteins on carboxylated europium(lll)-chelate embedded nanoparticles.
• monoclonal antibody or myoglobin was attached to the surface of the nanoparticle and, thereafter, the remaining free surface sites were occupied by antibody labelled with Alexa680 dye.
• the time-resolved fluorescence energy transfer signal was monitored at 730 nm.
• the competitive binding curve of the smaller myoglobin protein (molecular weight 17 000, diameter ⁇ 3 nm) has shifted to higher concentration compared to the larger monoclonal antibody protein (molecular weight 160 000, diameter -10 nm) indicating size difference between the sample substances.
• Figure 11 illustrates a concentration measurement of bovine serum albumin on carboxylated microparticles using two-photon excitation technology.
• bovine serum albumin was attached to the surface of the microparticle and, thereafter, the BF530-dye embedded nanoparticles were adsorbed to the microparticle-bound bovine serum albumin.
• Two-photon excitation based TPX system was used to measure microparticle-bound BF530 nanoparticles at 560 nm.
• Figure 12 the principle of enzyme-based analysis.
• the solid phase contains an enzyme-specific substrate (A).
• the sample substance binds nonspecifically onto the solid-support blocking the access of enzyme to its binding partner (B). If less sample substance is added a larger signal is monitored because more substrate is available for enzyme-mediated cleavage and signal generation.
• A enzyme-specific substrate
• B binding partner
• the present invention relates to a method of determining concentration of a sample substance.
• the invention relates to a method of determining unit size of a sample substance.
• the invention relates to a method of determining charge of a sample substance. Typical for the invention is that concentration, charge or size is being measured using a nonspecific interaction between solid-phase surface and sample substance or a complex containing sample substance as well as the proximity principle. The method can be used in measuring concentration, charge or size of sample substances in biological, organic or inorganic samples or in mixtures of such samples.
• concentration shall be understood as any unit per volume of liquid or gas.
• size shall be understood as any measure of length, volume or repeating units of a sample substance.
• solid-phase or “surface” shall in this text be understood as any separable form of material. Thus it can be a particle or solid support such as polymer, glass, or silica substrate.
• Particle means generally a particulate in the size region from 0.5 nm to 100 000 nm, preferably from 0.5 nm to 10 000 nm, more preferably from 0.5 nm to 1000 nm and most preferably from 0.5 nm to 500 nm.
• the particles may be unstable in solution. This means that particles may sedimentate within a relatively short period of time.
• the particles remain in solution for at least 1 hour, more preferably 3 hours and even more preferably 6 hours and most preferably 12 hours.
• particle solution may be stable in solution.
• particle solution is colloidal, i.e. a stable dispersion of particles in solution.
• Particles can take any form, for example spherical, elliptic, rod or irregular shape.
• the particle can be formed from single entity, multiple entities, multiple different entities or an agglomerate of one or multiple entities.
• the size distribution of the solid phase can be unimodal (monodisperse) or multimodal (polydisperse).
• Proximity refers to the principle of a detection method where a signal is generated by close vicinity to a solid-phase and a substance containing a signal element or a sample substance comprising an inherent signal element. This may or may not mean that the sample substance is in contact with the surface.
• the signal may be generated by having a competitive substance in the detection volume. In such a case, the competitive substance carries a signal-generating unit and it competes for close vicinity to the solid-phase surface with the sample substance simultaneously or in sequential steps.
• Nonspecific binding is determined as follows: The surface of the solid surface contains no specific binders to the sample substance.
• a solid surface containing an antibody selectively binds to an antigen or a group of antigens with high affinity. Such a binding event is considered specific.
• structure- recognizing surfaces as achieved using molecular imprinting are considered specific in this context.
• Specific binders recognize their ligands, analogues of the ligands and structures very similar to the ligand with high affinity - typically higher than 10 7 M '1 (affinity constant).
• Specific binders have high selectivity towards their ligands, analogues of the ligands and structures very similar to the ligand Molecular recognition elements (i.e.
• the surface contains no specific binders at all, or preferably none of the above-mentioned specific binders, it is according to the invention considered a nonspecific binding surface where the sample may be adsorbed or bound.
• the surface of the solid-support may or may not contain one or multiple functional groups, typically selected from the group consisting of -COOH, -NH 2 , -CHO, -OH, -maleimide, -succinimide, -epoxy and polymers (such as polyimide or grafted groups) whereto sample substance can be physically or chemically bonded or adsorbed.
• the solid surface containing surface groups do not contain specific binders and accordingly surface groups do not specifically bind sample substances compared to essentially similar molecules.
• resonance energy transfer relates to a method, where donor compound is in a close vicinity to acceptor compound. This generates an energy flow from the donor to the acceptor leading to a detection scheme where signal is monitored through the donor or acceptor.
• a method is well known for example in fluorescence resonance energy transfer system where donor dye can be down or up converting dye.
• donor dye can be down or up converting dye.
• the donor is excited and as a consequence of the proximity principle acceptor dye is excited by the donor compound and signal is detected at the emission wavelength of the acceptor compound.
• resonance energy transfer methods such as fluorescence, time-resolved fluorescence, bioluminescence and luminescence resonance energy transfer.
• the resonance energy transfer can be considered as signal generating method or a method where signal is quenched.
• any element can be used to quench signal such as a dye or metal.
• Typical metal chelators used in time-resolved fluorometry are 3-(2-thienoly)-1 ,1 ,1-trifluoroacetone, 3-benzoyl- 1 ,1 ,1-trifluoroacetone, coproporphyrins, porphyrins, 3-naphthoyl-1 ,1 ,1-trifluoro- acetone, 2,2-dimethyl-4-perfluorobutyoyl-3-butanone, 2,2'-dipyridyl, phenanthro- line, salicylic acid, phenanthroline carboxylic acid, aminophenanthroline, diphenyl- phenantroline, dimethylphenanthroline, bipyridylcarboxylic acid, aza crown ethers, trioctylphosphine oxide, aza cryptands, dibenzoyl methane, dinap
• luminairestaviral oxygen channeling immunoassay refers here to a method where singlet oxygen is being transferred from its host compound or matter to an acceptor compound or matter when singlet oxygen host and acceptor are in a close vicinity to one another. Typically a particle donor and acceptor are used in the method. (Ullman E. F. et al. Clin. Chem. 1996:42;1518)
• Radioactive label is in close vicinity to matter, which is capable of transforming radioactive emitters to light or other form of detectable signal.
• the matter can be a particle or solid- support.
• Tro-photon excitation is a method, which relies on a small detection volume.
• the small volume separates the detection volume from the surrounding medium allowing separation-free assay format.
• dyed substance is bound to a solid-phase particle on which the concentration of the sample substance of interest is detected.
• Coincidence assay format is an assay concept where two differently dyed particles are coated with e.g. antibodies. As an analyte molecule couples two differently dyed particles together, the presence of the analyte is being measured by detecting the presence of both dyed particles in a small volume. For example, two-photon excitation can be used to reduce the detection volume and separate the two-particle complex from the surrounding medium without any physical separation. The method also allows a concept where only one dyed particle is being used. The other particle can be replaced with soluble dyed substance. (Heinze K.G. Biophys. J. 2002:83;1671 , Heinze K.G. Biophys. J. 2004:86;506)
• Fluorescence polarization assay refers to a method where polarization property of a dyed molecule is altered upon contact with another molecule. As the small dyed molecule is freely moving and rotating in medium, low polarization value is measured because movement and rotation occurs fast. As the small dyed molecule is attached to a larger molecule such as to a particle, its polarization is altered and a larger polarization value is measured. (Park S. H. et al. Methods MoI. Biol. 2004:261 ;161 )
• Fluorescence correlation spectroscopic assay can be constructed using a particle and a dyed substance. As the dyed substance is being attached to the particle its fluorescence fluctuation pattern alters leading to a change in signal from freely fluctuating dyed substance. (Krichevsky O. at al. Rep. Prog. Phys. 2002:65; 251)
• Flow cytometric assay is a separation-free assay format where particles are used as a solid-support and dyed substance is attached on the surface of the particle. Thereafter, the extent of dyed substance is being detected through a flow cytometric system.
• the particles used are typically labelled with fluorochromes to identify each particle.
• Enzyme-based assay relates to an assay format where substrate has been attached on a particle or solid-support and soluble enzyme reacts with the solid- phase bound substrate molecule generating a detectable signal.
• substrate on a solid support is typically a small compound, it can be blocked or coated with samples of interest blocking the enzyme activity. The change in the signal is evident as the enzyme is not capable of reacting with the substrate and generating signal ( Figure 12).
• Electrode-based method can be constructed using a group capable of releasing or receiving an electron.
• substances labelled with ruthenium complexes are allowed to compete with a sample substance. As the labelled substance is in a close vicinity to an electrode, light is generated as the ruthenium complex undergoes a redox cycle.
• a lanthanide chelate labelled substance is allowed to compete with a sample substance. As the labelled substance is in a close vicinity to an electrode, light is generated.
• Nephelometry or turbidimetry utilizes the enhanced scattering signal caused by particles. Typically, particles aggregate upon addition of sample substance. (Price CP. at al. In Principle and practice of immunoassay. Macmillan Reference Ltd., London, UK, 1997;579)
• Scattering material refers to particles, for example gold or silver particles, and, when referring to surface-enhanced Raman scattering material, it can refer to, e.g. gold or silver particles coated with fluorescent molecules such as cyanine dye. Such scattering material can be used to recognize sample substance nonspecifically. (Ni J. et al. Anal. Chem. 1999:71 ;4903, Schultz S. Proc. Natl. Acad. Sci. U.S.A. 2000:97;996)
• Conducting metal particles have typically resonance effects. These resonance effects can be utilized according tq the invention to obtain a measurable signal.
• the resonance effects of silver or gold nanoparticles can be used to enhance the fluorescence signal of fluorochromes close to the surface of the particles.
• a sample substance can affect this signal when nearing the surface or when adsorbed onto the surface.
• Magnetic solid surfaces can be utilized according to the invention to generate a signal.
• a sample substance is adsorbed on a solid surface non-specifically, and magnetic particles are used to bind nonspecifically to the sample substance, and the presence of the sample substance on the solid surface can be detected.
• the change in signal can occur when the sample substance or substance containing a signal element is attached to or is nearing the solid-support.
• the attachment can occur through physical or chemical bonding or adsorption.
• the change in signal can occur when the sample or substance containing a signal element is in a close proximity to the solid-support without any physical or chemical bonding or adsorption.
• adsorption refers to the phenomena wherein substances accumulate on a solid phase forming a molecular layer on the surface due to intermolecular attraction forces, i.e. van der Waals forces and not due to true chemical bonds, i.e. covalent bonds through electron share.
• the methods listed above are based on the detection of luminescence such as fluorescence, phosphorescence, time-resolved fluorescence or up-converting fluorescence.
• the light may be generated using radioactivity, electrons, singlet oxygen or enzyme substrates. Also detection methods based on resonance effects, scattering or magnetic signal can utilized.
• a signal element of the solid-phase is affected by the sample substance in a close vicinity to the solid-phase surface, to obtain a detectable change in the signal of the signal element of the solid-phase surface or the signal of an inherent signal element of the sample substance that may be affected by the proximity of the solid-phase surface.
• the sample substance can aggregate solid- phase particles changing the signal or scattering properties from those of non- aggregated particles.
• the sample substance is attached to the surface or nearing the surface nonspecifically.
• the sample substance can compete with a competitive substance for the proximity of the solid-phase surface.
• the competitive substance contains an element, which affects the signal of the solid-phase surface or the solid-phase surface contains an element, which affects the signal of the competitive substance.
• the competitive substance may have a high specificity and affinity toward the surface of the solid- phase surface. Typical is that the sample substance is capable of blocking the surface nonspecifically.
• the sample substance is interacting with a second substance in a specific or nonspecific manner. This may occur competitively when using a competitive substance containing a signal element.
• the competitive substance may interact with the sample substance or the second substance.
• the mixture of the complex, free sample substance, free substance containing a signal element and free second substance are brought in close vicinity to the solid-phase surface.
• the proximity of the mixture of the complex, the sample substance, the second substance and the competitive substance containing a signal element, in contact or near the solid-phase surface causes a detectable change in the solid-phase surface signal.
• the complex analysis can be used to detect a specific class of substances in the sample to be analyzed.
• the complex analysis according to the invention allows also interaction of, first, sample substance and, thereafter, the second labelled substance having an affinity toward the sample.
• the second substance may interact with the sample substance in a specific or nonspecific manner.
• the principles of the surface recognition and the competition analyses can be applied in the complex analysis. Typically no specific binders are used to couple the complex, free sample substance, free substance containing a signal element and/or free second substance onto the surface.
• Analyses can be performed using two or more solid surfaces.
• a sample substance is in a close vicinity to a solid surface.
• the presence of the sample substance is recognized using a second solid surface for example a particle containing a signal element.
• the sample substance may be bound to the solid surface through specific or nonspecific interaction. Typical is that the particle containing the signal element has no specific interaction with the sample substance.
• both solid surfaces may contain a signal element.
• the method can also be used by, first, allowing interaction of the sample substance and the particle, followed by adsorption onto the solid surface.
• the solid surface can be a solid material or a membrane containing pores or it can be made of nonporous material. The principles of surface recognition, competition and the complex analyses can be applied in multi surface analysis.
• a number of detection methods is based on focally limited volume in order to reduce background signal. This can be achieved for example using two-photon excitation, confocal or macroconfocal detection principles. In such methods the solid surface may or may not contain signal element. Therefore, the focal limitation analysis allows using a non-labelled solid surface. Detection technologies that can be used are for example cell counting by monitoring cells labelled nonspecifically with particles containing a signal element. The principles of surface recognition, competition, complex and the multi surface analyses can be applied in focally limited analysis.
• Surface recognition, competition, complex, multi surface, and focally limited analysis can be performed in a separation-free assay format without any need for a washing step.
• surface recognition, competition, complex, multi surface and focally limited analyses can be performed in a heterogeneous assay format where a washing step is required.
• At least the solid phase comprises a signal element.
• at least the sample substance comprises an inherent signal element.
• the signal element substance is employed.
• the signal element substance is a specific binding partner, which specifically binds with the sample substance, forming a complex which binds nonspecifically to the solid phase.
• the sample substance can bind to the solid phase and to a particle containing the signal element substance.
• the signal element substance competes with the sample substance in binding to the solid phase.
• a specific binding partner which specifically binds with both the signal element substance and the sample substance, is contacted in step a) with the sample substance and the solid phase, and both the sample substance and the signal element substance forming complexes with the specific binding partner which complexes bind to said solid phase.
• the signal element substance is an enzyme substrate comprised in the solid phase; and an enzyme, capable of releasing a signal product from the signal element substance (if the signal element substance is not blocked by the sample substance bound or nearing the solid phase), is contacted in step a) with the sample substance and the solid phase.
• At least two different signal elements are employed and at least one signal element comprises one member of a label pair, and at least another signal element comprises the other member of the label pair, wherein the label pair is i) a resonance energy transfer label pair ii) a luminescent oxygen channeling immunoassay label pair, or iii) a scintillation label pair.
• a detection principle involving focal limitation preferably two-photon excitation, confocal or macroconfocal methods, is utilized.
• the analyses of the methods of the invention can be performed in separation or separation-free format.
• the signal change is used to measure the total concentration of the sample substance, the charge of the sample substance and/or the unit size of the sample substance.
• the method of invention can be applied to measure a unit size of a sample substance.
• the unit size of a sample substance may vary from 0.1 nm to 100 000 nm in diameter.
• the unit size of a sample substance can be measured in solution or gas constituting of single sample substance or a mixture of sample substances.
• the method can be used in detecting the size of a polypeptide.
• the method of invention can be used to measure unit size of a class of polypeptides.
• Particle surface may be constructed in a way that it discriminates between molecules of different sizes, such as DNA fragments of different length - large DNA is attached onto the solid- phase while short DNA is not. The surface is still not specifically constructed to bind DNA.
• the surface may well contain, for example, positive surface groups, which captures DNA but it also captures other polypeptides, for example, proteins.
• the unit size can be measured, for example, using a known concentration of sample substance. According to the Stokes-Einstein relationship, diffusion is inversely related to the size of a substance. Therefore, a large sample substance has lower diffusion rate than a smaller sample substance. This rate can be utilized to measure the change in proximity signal and it can be related to the size of the sample substance. According to another strategy, the unit size of sample substance can be measured using the size-related change in proximity signal. Having the same concentration of samples substances, a large sample substance occupies a larger area on a solid-phase than a smaller sample substance. This may lead to a larger or different signal change in the case of larger sample substance. For example, a protein or aggregate form of the protein results in a different signal on a solid-phase due to different binding area.
• the unit size can be measured using different binding properties of sample substance on a solid-phase.
• a large sample substance may bind on a solid-phase with a lower efficiency than a smaller sample substance or a smaller sample substance may bind on a solid-phase with a lower efficiency than a larger sample substance leading to a different change in proximity signal.
• the method of invention can be used to determine charge of the sample substance.
• sample substance For example, in biochemistry, typically, protein pi value is measured and in polymer sciences, typically, particle surface charge is measured.
• the charge of sample substance can be measured using the size-related change in proximity signal. Having the same concentration of sample substances, a large sample substance may contain larger surface charge than a smaller sample substance. This may lead to a more efficient binding on a solid-phase and a larger signal change in the case of larger sample substance.
• nucleic acids and aggregate or hybridized form of the nucleic acids results in different signal on a solid-phase due to different binding efficiency toward the surface of a solid-phase.
• pH or salt concentration of a solution can be changed to bind differently charged substances onto solid phase.
• two proteins with pi values of 5 and 8 can be tested by varying pH.
• pH is chosen to be 3 both proteins carry positive charge and bind onto solid phase containing negative surface charge.
• sample refers to a substance or substances to be analyzed, i.e. sample substance or substances, and optionally a carrier. Alternatively, the sample may contain the sample substance or substances only. The sample may contain solely a single substance.
• a sample substance can be any compound below 100 000 nm in diameter.
• the sample substance may appear in any form such as protein, nucleic acid, organic or inorganic substance, polymer, agglomerate, vesicle, liposome, particle or dyed particle as well as organism such as virus, bacterium or cell. Alternatively the sample substance may appear in mixtures of above- mentioned substances.
• sample substance may appear in a fragmented or disintegrated form where for example larger units, such as cells, are partially or totally broken into fragments or parts of said units.
• the sample substance can also be a biomolecule on a surface of any structure such as virus, bacterium, cell, vesicle, liposome, particle, polymer or any substance.
• the sample substance to be analyzed may inherently contain a signal element such as fluorescent or colour group, substrate for enzyme or the sample substance can be, for example, a fluorescent protein or particle.
• the substance containing a signal element can be, for example, protein, nucleic acid, organic or inorganic substance, polymer, agglomerate, vesicle, liposome, particle or dye particle as well as organism such as virus, bacterium or cell.
• the signal element of the substance can be for example a luminophore, fluorescent protein, radioactive label, light producing or absorbing element, cleavable light producing or absorbing substrate for an enzyme, electron receiving or releasing material, scatterer, conducting metal, semiconductor material, magnetic material or singlet oxygen producing element.
• the signal element may also be solid material containing a luminophore, fluorescent protein, radioactive label, light producing or absorbing groups, cleavable light producing or absorbing substrate for an enzyme, electron receiving or releasing solid material, scattering groups, conducting metal, semiconductor material or singlet oxygen producing material. This is dependent on the method used. Any method can be used to attach the element to the competitive substance such as physical or chemical coupling.
• the signal element of the solid-phase surface may be any element arising from the proximity methods or any of the following signal elements: luminescent, fluorescent, phosphorescent, light producing or absorbing element, cleavable light producing or absorbing substrate for an enzyme, time-resolved fluorescent or up- converting fluorescent element.
• the signal may also be generated using radioactivity, enzymes, electrons or singlet oxygen. Also detection methods based on resonance effects, scattering or magnetic signal can utilized.
• a single signal element or multiple signal elements can be used. Cascades of different signal elements can also be utilized for example a combination of two or more dyes capable of undergoing resonance energy transfer between one another.
• the signal element may be inside the surface of the solid-support.
• the signal element may be attached to the solid-support by means of physical or chemical bonding or adsorption.
• the signal element may be coupled to a compound, which is attached onto or into the solid-support.
• the solid phase may not contain any signal element.
• the solid support may be, for example, organic or inorganic material such as metal, semiconductor material or polymer. According to the invention also porous materials can be used.
• the size of a pore may be chosen to allow penetrating a reaction substance so that larger molecules cannot penetrate into the pores but smaller molecules are capable of penetrating. Essential is that no specific binding partners or specific binding pockets using imprinting technology is used to bind or allow the penetration the sample substance into the pores.
• kinetic and nonspecific binding properties can be aided using physical or chemical methods.
• sonication can be conducted, pH, temperature or salt concentration can be varied or chaotropes can be added.
• sonicating by varying pH, temperature, salt concentration or by adding chaotropes breakage or denaturation of, for example, proteins or cells may occur leading to enhanced binding properties or increasing the number of detecting units.
• breaking of a cell exposes cytoplasmic components into the reaction volume increasing the number of biomolecules in the reaction volume.
• a total concentration of sample substance can be measured.
• a separation step prior to the reaction may be required. This may well be the case in counting, for example, cells.
• Various separation methods can be, therefore, combined with the invention, for example, chemical or physical separation methods, centrifugation, aggregation, filtration or dialysis.
• the analysis can be performed in an aqueous or organic phase or in a mixture of the two phases.
• the analysis can also be performed in an aqueous and/or organic phase in combination with a gaseous phase.
• the method of invention can be used in multiple instrument setups. Whenever the sample substance must be excited with light, different configuration can be used to measure the concentration, charge or unit size of the substance successfully.
• the light source of such a measurement configuration can be, for example, halogen, xenon, tungsten, hydrogen or deuterium lamp or laser or semiconducting light source such as light emitting diode.
• the detector can be, for example, photoemissive, photomultiplier or semiconductor detector such as photodiode.
• the detecting configuration may occur by having the light source on one side of the measurement container and the detector on the other side. The light source and detector may well have an angle in between them. Often used setup is epiconfiguration (180 degree). Well-known methods such as filters, monochromators, prisms or gratings can be used to select suitable excitation and emission wavelength in case of optical configuration.
• the method according to this invention can be used to measure concentration, charge or unit size of a sample substance in many various fields such as biology, biochemistry, chemistry, medicine, diagnostics, forensics, military, food industry, paper and pulp industry, paint industry, cosmetics. .
• the current invention provides several advantages.
• the invention provides very simple means for determining concentration, charge or unit size of a sample substance of interest. For example, typically a sample is mixed with solid-phase and optionally with a labelled competitive substance and the signal is monitored within a short period of time.
• the method does not require addition of further substances, change in temperature or pH, separation of bound and unbound components and long incubation times. No prior knowledge of light absorption properties is required. This is contrary to existing methods where molar absorptivity must be known, pH or temperature must be changed or long incubation times must be conducted for successful analysis.
• the method can be applied to many different areas of interest because both aqueous and organic solvents can be used to run an analysis. In addition, the method is highly sensitive.
• the distance between donor and acceptor molecules may be very short.
• the distance is shorter than typically in a bioaffinity assay because the acceptor labelled substance is directly attached to the surface of the donor solid- phase surface and not through specific binding partner which increases the distance between the donor and the acceptor.
• This improves the sensitivity of the analysis as well as dynamic range of the analysis.
• high interaction tendency of sample substance with the solid phase improves the analysis performance.
• the sensitivity improvement can be a result of the reduced background due to the reduced number of proximity label pairs as more signal is available. Still another advantage can be found in favour of the invented method compared to the existing technologies for determination of concentration.
• the fluorochrome is typically coupled to a protein through amine or thiol groups.
• the Bradford method utilizes the very same groups in coupling the Bradford reagent to proteins to generated colour in solution. Therefore, it is difficult to standardize the method as similar protein with the same number of available functional groups should be found.
• the method of invention does not severely discriminate between substances and their dyed formats in attachment of the sample substance onto the solid-phase.
• the current invention also allows constructing inexpensive instrumentation.
• Carboxylated europium(ll!)-chelate embedded 107 nanometer particles were used as obtained from the manufacturer (Seradyn Inc, Indianapolis, IN). The nanoparticles were incubated with different concentrations of bovine serum albumin in 50 ⁇ l_ of 20 mM phosphate buffer, pH 7, for 10 min. Bovine serum albumin was adsorbed onto the nanoparticles. Thereafter, 10 ng of bovine serum albumin labelled with commercial N-hydroxysuccinimide Alexa680 dye (Molecular Probes, Eugene, OR) was added to the sample-nanoparticle solution in 20 ⁇ l_. The Alexa680-dyed bovine serum albumin occupied the remaining free sites on the nanoparticle.
• the solution was incubated for 10 min and measured for long-lived fluorescence signal at 730 nm using DELFIA 1234 time-resolved fluorescence plate reader (PerkinElmer Life and Analytical Sciences, Boston, MA).
• the excitation wavelength was 340 nm
• the decay time of the measurement was 75 ⁇ s
• the window time was 75 ⁇ s.
• the europium(lll)-chelate nanoparticle acted as a donor and Alexa ⁇ O dye coupled to the bovine serum albumin served as an acceptor.
• the results are presented in Figure 6. _
• Cy5-labelled surface was prepared by coupling N-hydroxysuccinimide-Cy5 dye (Amersham, Buckinghamshire, UK) to an amino silane solid surface (silanized quartz). Phosphate buffer, 20 mM, pH 7, or phosphate buffer containing 100 ng of bovine serum albumin were incubated on the Cy5-surface in a 5 ⁇ l_ volume for 45 min. Both solutions contained 50 ng of europium(lll)-labelled streptavidin as a competitive substance.
• the label used was 2,2 ' ,2 " ,2 '" -((2-(4-isothiocyanato- phenyl)ethylimino)-bis(methylene)bis(4-((4-( ⁇ -galactopyranoxy)phenyl)ethynyl)-py- ridine-6,2-diyl)bis(methylenenitrilo))-teterakis(acetato))europium(lll).
• Europium(III)- labelled streptavidin was adsorbed onto the surface if no bovine serum albumin was in the solution. The europium(IH)-labelled streptavidin acted as a donor and Cy5 dye coupled to the surface served as an acceptor.
• a silver surface was prepared through physical vapour deposition technique. Phosphate buffer, 20 mM, pH 7, or phosphate buffer containing 100 ng of bovine serum albumin were incubated on the silver surface in a 5 ⁇ L volume for 45 min. Both solutions contained 50 ng of europium(lll)-labelled streptavidin as a competitive substance.
• the label used was 2,2 ' ,2",2 '" -((2-(4-isothiocyanato- phenyl)ethylimino)-bis(methylene)bis(4-((4-( ⁇ -galactopyranoxy)phenyl)ethynyl)-py- ridine-6,2-diyI)bis(methylenenitrilo))teterakis(acetato))europium(lll).
• Europium(lll)- labelled streptavidin was adsorbed onto the surface if no bovine serum albumin was in the solution. The europium(lll)-labelled streptavidin acted as a donor and metallic silver on the surface served as a quencher.
• the long-lived fluorescence energy transfer signal was monitored at 615 nm using Victor 1420 time-resolved fluorescence plate reader.
• the excitation wavelength was 340 nm
• the decay time of the measurement was 400 ⁇ s
• the window time was 400 ⁇ s.
• Carboxylated europium(ll!-chelate embedded 107 nanometer particles were used as obtained from the manufacturer (Seradyn Inc, Indianapolis, IN). The nanoparticles were incubated with different concentrations of estradiol in 100 ⁇ l_ of 100 mM phosphate buffer, pH 7, for 10 min. Estradiol was adsorbed onto the nanoparticles. Thereafter, 10 nM solution of estradiol labelled with commercial N- hydroxysuccinimide Alexa680 dye (Molecular Probes, Eugene, OR) was added to the sample-nanoparticle solution in 50 ⁇ l_. The Alexa680-dyed estradiol occupied the remaining free sites on the nanoparticle.
• the solution was incubated for 10 min and measured for long-lived fluorescence signal at 730 nm using DELFlA 1234 time-resolved fluorescence plate reader (PerkinElmer Life and Analytical Sciences, Boston, MA).
• the excitation wavelength was 340 nm
• the decay time of the measurement was 75 ⁇ s
• the window time was 75 ⁇ s.
• the europium(lll)- chelate nanoparticle acted as a donor and Alexa680 dye coupled to the estradiol served as an acceptor.
• the results are presented in Figure 8.
• Carboxylated europium(lll)-chelate embedded 107 nanometer particles were used as obtained from the manufacturer (Seradyn Inc, Indianapolis, IN). The nanoparticles were incubated with different concentrations of five different cell types in 50 ⁇ L of 20 mM phosphate buffer, pH 7, for 10 min. Cells were adsorbed onto the nanoparticles. Thereafter, 10 ng of bovine serum albumin labelled with commercial N-hydroxysuccinimide Alexa680 dye (Molecular Probes, Eugene, OR) was added to the cell-nanoparticle solution in 20 ⁇ L. The Alexa680-dyed bovine serum albumin occupied the remaining free sites on the nanoparticle.
• the solution was incubated for 10 min and measured for long-lived fluorescence signal at 730 nm using DELFIA 1234 time-resolved fluorescence plate reader (PerkinElmer Life and Analytical Sciences, Boston, MA).
• the excitation wavelength was 340 nm
• the decay time of the measurement was 75 ⁇ s
• the window time was 75 ⁇ s.
• the europium(lll)-chelate nanoparticle acted as a donor and Alexa ⁇ O dye coupled to the bovine serum albumin served as an acceptor.
• the results are presented in Figure 9.
• carboxylated europium(lll)-chelate embedded 107 nanometer particles were utilized.
• the nanoparticles were incubated with different concentrations of monoclonal antibody or myoglobin in 50 ⁇ L of 20 mM phosphate buffer, pH 7, for 10 min.
• the proteins were adsorbed onto the nanoparticles.
• Monoclonal antibody and myoglobin have a molecular weight and size of 160 000, diameter ⁇ 10 nm and 17 000, diameter ⁇ 3 nm, respectively.
• 10 ng of antibody Fab fragment labelled with N-hydroxysuccinimide Alexa ⁇ O dye was added to the sample-nanoparticle solution in 20 ⁇ L.
• the Alexa680-dyed Fab fragment occupied the remaining free sites on the nanoparticle.
• the solution was incubated for 10 min and measured for long-lived fluorescence signal at 730 nm using DELFIA 1234 time-resolved fluorescence plate reader.
• the excitation wavelength was 340 nm
• the decay time of the measurement was 75 ⁇ s
• the window time was 75 ⁇ s.
• the europium(lll)- chelate nanoparticle acted as a donor and Alexa680 dye coupled to the Fab fragment served as an acceptor.
• the different size of the proteins resulted in significantly different binding curves. The results are presented in Figure 10.
• Carboxylated 3.2 micrometer particles were used as obtained from the manufacturer (Bangs Laboratories, Fishers, IN). The microparticles were incubated with different concentrations of bovine serum albumin in 15 ⁇ L of 20 mM phosphate buffer, pH 7, for 10 min. Bovine serum albumin was adsorbed onto the microparticles. Thereafter, 50 000 BF530-labelled nanoparticles of 53 nm in diameter (Arctic Diagnostics, Turku, Finland) was added to the sample- microparticle solution in 10 ⁇ L. The BF530-nanoparticles attached to the microparticle bound bovine serum albumin.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Immunology (AREA)
• Engineering & Computer Science (AREA)
• Chemical & Material Sciences (AREA)
• Molecular Biology (AREA)
• Biomedical Technology (AREA)
• Hematology (AREA)
• Urology & Nephrology (AREA)
• Biotechnology (AREA)
• Biochemistry (AREA)
• Cell Biology (AREA)
• Food Science & Technology (AREA)
• Medicinal Chemistry (AREA)
• Physics & Mathematics (AREA)
• Analytical Chemistry (AREA)
• Microbiology (AREA)
• General Health & Medical Sciences (AREA)
• General Physics & Mathematics (AREA)
• Pathology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
• Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Priority Applications (2)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (1)

Family

ID=38227947

Family Applications (1)

Country Status (2)

Cited By (3)

Families Citing this family (1)

Citations (9)

• 2006
  • 2006-12-29 WO PCT/FI2006/000427 patent/WO2007077291A1/en active Application Filing
  • 2006-12-29 EP EP06830933A patent/EP1994407A4/de not_active Withdrawn

Patent Citations (9)

Non-Patent Citations (28)

Also Published As

Similar Documents

Legal Events